COVID-19 Vaccine Hesitancy in a Population-Based Study of Minnesota Residents DOI Creative Commons

Sallee Brandt,

Ryan T. Demmer,

Sara Walsh

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(4), P. 766 - 766

Published: March 30, 2023

COVID-19 continues to be a public health concern in the United States. Although safe and effective vaccines have been developed, significant proportion of US population has not received vaccine. This cross-sectional study aimed describe demographics behaviors Minnesota adults who primary series vaccine, or booster shot using data from Antibody Study (MCAS) collected through population-based sample between September December 2021. Data were web-based survey sent individuals that responded similar 2020 their adult household members. The was 51% female 86% White/Non-Hispanic. A total 9% vaccine-eligible participants had 23% those eligible receive it. Older age, higher education, better self-reported health, $75,000 $100,000 annual income, mask-wearing, social distancing associated with lower odds hesitancy. Gender, race, previous infection most frequently reported reason for receiving vaccination safety concerns. Mask-wearing being age 65 older only strong predictors vaccine hesitancy both analyses.

Language: Английский

Predictors of second COVID‐19 booster dose or new COVID‐19 vaccine hesitancy among nurses: A cross‐sectional study DOI
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa

et al.

Journal of Clinical Nursing, Journal Year: 2022, Volume and Issue: 32(13-14), P. 3943 - 3953

Published: Nov. 7, 2022

Abstract Aims and objectives To assess the levels of second COVID‐19 booster dose/new vaccine hesitancy among nurses explore potential predictors hesitancy. Background full vaccination seems to be highly effective against contagious variants SARS‐CoV‐2. Healthcare workers are at high‐risk group since they have experienced high COVID‐19‐associated morbidity mortality. Design An on‐line cross‐sectional study was carried out in Greece May 2022, using a self‐administered questionnaire. Methods The population included healthcare services who were fully vaccinated time study. We considered socio‐demographic characteristics, COVID‐19‐related variables, attitudes toward pandemic as applied STROBE checklist our Results Among 795 nurses, 30.9% hesitant dose or new vaccine. Independent lower educational level, absence chronic condition, good/very good self‐perceived physical health, lack flu during 2021, front‐line that provided patients, had not been diagnosed with least one relative/friend has died from COVID‐19. Moreover, increased compliance hygiene measures, fear decreased trust associated Conclusions Our shows significant percentage This initial could barrier efforts control pandemic. Relevance clinical practice Nurses' role is essential empowering public their passion empathy. There need communicate science way accessible order decrease Patient contribution No patient contribution.

Language: Английский

Citations

25

Hesitancy to Receive the Second COVID-19 Vaccine Booster Dose among Older Adults in Hong Kong: A Random Telephone Survey DOI Creative Commons
Paul Chan,

Marco Lok-tin Lee,

Yuan Fang

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(2), P. 392 - 392

Published: Feb. 8, 2023

A second COVID-19 vaccine booster dose is effective and safe for older adults. This study investigated hesitancy to take up a its determinants among adults in Hong Kong. Participants were Chinese-speaking community-dwelling aged 65 years or above. Telephone numbers randomly selected from up-to-date telephone directories. total of 370 participants completed the survey. Logistic regression models fitted data analysis. Among participants, half (52.4%) hesitant receive dose. After adjustment significant background characteristics, perceived benefits (AOR: 0.50, 95%CI: 0.42, 0.60), cues action 0.39, 0.30, 0.52), self-efficacy 0.37, 0.21, 0.66) receiving associated with lower hesitancy. Perceived barriers 1.23, 1.12, 1.34) fatigue (tired repeated vaccination) 1.90, 1.52, 2.38) higher Level was high Health authorities should address modify perceptions related

Language: Английский

Citations

14

Assessing acceptability of the fourth dose against COVID-19 among Chinese adults: A population-based survey DOI Creative Commons
Chenyuan Qin, Min Du, Yaping Wang

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2023, Volume and Issue: 19(1)

Published: Jan. 2, 2023

Coronavirus disease 2019 (COVID-19) has wreaked havoc across the globe for approximately three years. Vaccination is a key factor to ending this pandemic, but its protective effect diminishes over time. A second booster dose at right time needed. To explore willingness receive fourth of COVID-19 vaccine and influencing factors, we commenced national, cross-sectional anonymous survey in mainland China among people aged 18 above from October 24 November 7, 2022. total 3,224 respondents were eventually included. The acceptance rate was 81.1% (95% CI: 79.8–82.5%), while it 72.6% 71.1–74.2%) heterologous booster. Confidence current domestic situation effectiveness previous vaccinations, uncertainty about extra protection main reasons hesitancy. Perceived benefit (aOR = 1.29, 95% 1.159–1.40) cues action 1.73, 1.60–1.88) positively associated with acceptance, whereas perceived barriers 0.78, 0.72–0.84) self-efficacy 0.79, 0.71–0.89) both negatively it. Additionally, sex, age, vaccination history, social media, satisfaction government's response also factors affecting intention. Factors intention similar results. It profound theoretical practical significance clarify population's vaccinate advance relevant subsequent development promotion fourth-dose strategies.

Language: Английский

Citations

14

Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic DOI Creative Commons
Aglaia Katsiroumpa, Panayota Sourtzi, Δάφνη Καϊτελίδου

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(2), P. 331 - 331

Published: Feb. 1, 2023

High-risk populations are at increased risk of severe influenza-related illness, hospitalization, and death due to influenza. The aim our study was assess the willingness high-risk take influenza vaccine for 2022-2023 season, investigate factors associated with such willingness. We conducted a cross-sectional in Greece September 2022 using convenience sample. considered demographic characteristics, COVID-19-related variables, resilience, social support, anxiety, depression, burnout as potential predictors. Among participants, 39.4% were willing accept seasonal vaccine, 33.9% unwilling, 26.8% hesitant. Multivariable analysis identified that age family support vaccination Moreover, participants have received COVID-19 booster doses more vaccine. In contrast, adverse effects because exhaustion measures against reduced found intention receive low. Our contributes an understanding affect Public health authorities could use this information update programs Emphasis should be given on safety effectiveness issues.

Language: Английский

Citations

13

Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review DOI Creative Commons
Debendra Nath Roy, Nowrin Ferdiousi, Md. Mohabbot Hossen

et al.

Vaccine X, Journal Year: 2024, Volume and Issue: 18, P. 100480 - 100480

Published: March 23, 2024

The global deployment of COVID-19 vaccine booster dose (VBD) has been recognized as a promising therapeutic alliance to provide repeated immunity against the arrival new variants. Despite scientific evidence supports effectiveness periodic doses, reluctance continues thrive. This narrative review aimed examine doses acceptance and summarize an up-to-date assessment potential antecedents associated with VBD acceptance. A comprehensive search was performed in several reputable databases such Medline (via PubMed), Scopus, Google scholar, Web Science from June 10th, 2023, August 1st, 2023. All relevant descriptive observational studies on hesitancy were included this review. total fifty-eight (58) included, Asia representing highest count thirty-one (53 %) studies, Europe eleven (19 %), United States nine (16 other regions (Africa multi-ethnic) seven (12 %). Worldwide, pooled rate 77.09 % (95 CI: 76.28–78.18), willingness (n) = 164189, sample (N) 212,990. lowest reported American regions, respectively, 85.38 85.02–85.73, 32,047, (N 37,533) vs. 66.92 66.56–67.4), 29335, 43,832. However, multi-ethnic areas moderately high 79.13 78.77–79.23, 93,994, 11,8779) 72.16 71.13–72.93, 9276, 12,853), respectively. most common key across countries "equal safety", "efficacy", "effectiveness", post-vaccination "side effects", "community protection" "family protection", "risk-benefit ratio", necessity", "trust, "variants control". Disparities uptake observed globally, rates found Europe, regions. Multiple including safety, efficacy, side effects hesitancy.

Language: Английский

Citations

5

Seasonal Influenza Vaccine Intention among Nurses Who Have Been Fully Vaccinated against COVID-19: Evidence from Greece DOI Creative Commons
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(1), P. 159 - 159

Published: Jan. 11, 2023

Seasonal influenza continues to be a significant public health issue causing hundreds of thousands deaths annually. Nurses are priority risk group for vaccination and high vaccine uptake rate among them is crucial protect health. Thus, the aim our study was estimate levels acceptance, as well its determinants, nurses 2022/2023 season. We conducted cross-sectional with convenience sample in Greece. collected data via an online survey September 2022. Most possessed MSc/PhD diploma (56.2%) had previously been infected by SARS-CoV-2 (70.3%). Among nurses, 57.3% were willing accept vaccine, 19% hesitant, 23.7% unwilling. Older age, higher perceived support from others, COVID-19-related physical exhaustion positively related intention. In contrast, more side effects because COVID-19 due measures taken against negatively associated Since acceptance moderate, policymakers should develop implement tailored specifically context pandemic decrease hesitancy.

Language: Английский

Citations

12

Factors Influencing COVID-19 Vaccination among Primary Healthcare Nurses in the Pandemic and Post-Pandemic Period: Cross-Sectional Study DOI Creative Commons

Zorica Pristov,

Bojana Lobe,

Maja Sočan

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(6), P. 602 - 602

Published: May 31, 2024

The decision to vaccinate against COVID-19 is primarily a personal choice influenced by numerous factors. Vaccine acceptance and positive attitude towards vaccination among nurses have an impact on patients’ willingness vaccinate. To assess coverage primary healthcare associate socio-demographic factors, comorbidity, self-rated health, unhealthy lifestyle with the be vaccinated, we conducted online cross-sectional study from March May 2023 using self-administrated questionnaire. Probability sampling was used select 32 health centers were invited via email. Among 560 participants who completed survey, 78.3% 50.8% received two-dose course at least one booster dose of vaccine, respectively. Primary care ≥41 years age, physically less active, those overweight opted statistically significantly more often for scheme (p = 0.00, 0.015 0.017, respectively). Education living environments did not influence receive two doses. Likewise, good comorbidity contribute decision. Nurses that vaccinated doses 0.034) year age 0.000).

Language: Английский

Citations

4

Hesitancy towards COVID-19 booster vaccine among healthcare workers in Bangladesh DOI Creative Commons

Homayra Rahman Shoshi,

Ahamed Khairul Basher, Ashrak Shad Pyash

et al.

BMC Health Services Research, Journal Year: 2025, Volume and Issue: 25(1)

Published: March 6, 2025

Despite completing the COVID-19 vaccination series, healthcare workers (HCWs) remain at an elevated risk of re-infection. Booster uptake, though essential for this group, remains poorly characterized among Bangladeshi HCWs. This study identified prevalence and driving factors behind booster hesitancy HCWs, providing valuable insights targeted interventions. From December 2022 to June 2023, we conducted a cross-sectional survey 1772 HCWs enrolled from 20 facilities all tiers purposively selected across four administrative divisions Bangladesh. We collected information through face-to-face interviews regarding their sociodemographic, pre-existing, currently existing medical conditions, status, intention, hesitancy, willingness receive future doses. used multivariable logistic regression model analyze associated with hesitancy. Odd's ratio 95% confidence intervals (CIs) was calculated each factor, p < 0.05 considered statistically significant. Of interviewed in our study, 49% (879) were nurses [median age 36 years (IQR: 30.0-46.0)]; 69% female. Among respondents, 94% (1667) willing take booster, 6% (105) showed Safety concerns, especially potential side effects post-booster administration (86%), emerged as leading cause workers. Our analysis revealed that support staff, compared physicians, most hesitant any additional dose (aOR 4.68, CI: 1.56-9.03; p=0.006). Compared rural residency, urban residency type also more reluctant doses 4.45, 2.03-9.73; 0.001). Concerns about following primary driver study. Targeted interventions focusing on education addressing these anxieties-supported by evidence-based communication strategies-could play crucial role improving acceptance safeguarding vulnerable workforce.

Language: Английский

Citations

0

The Potential for Twice‐Annual Influenza Vaccination to Reduce Disease Burden DOI Creative Commons
Shuyi Zhong, Mark G. Thompson, Benjamin J. Cowling

et al.

Influenza and Other Respiratory Viruses, Journal Year: 2025, Volume and Issue: 19(3)

Published: March 1, 2025

Influenza vaccination is recommended annually based on the evolving nature of influenza viruses and waning vaccine-induced immunity. The timing usually before winter season in most temperate locations, where seasonality clear activities average last no longer than 6 months. However, many tropical subtropical areas have year-round activity multiple epidemics within 1 year, against which annual may not offer sufficient protection at individual level. A twice-annual program could utilize standard inactivated vaccines or enhanced vaccines. Here, we discuss three reasons to consider as a strategy improve protection. first, mentioned above, that some locations experience prolonged activity. second reason observation vaccine effectiveness significantly declines about months after particularly for A(H3N2) strains, therefore, twice year might be beneficial maintain higher level immunity half each year. third allow receipt updated given these are by World Health Organization. We also potential barriers challenges. first challenge knowledge gaps, because there very few existing studies used vaccination. barrier concern over whether more frequent would lead reduced immunogenicity clinical term. relates concerns cost feasibility. issues recommend comparative assessment incremental benefits versus vaccination, well other strategies aiming reduce disease burden can

Language: Английский

Citations

0

COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome DOI Creative Commons
Igor Portoghese,

Melinda Siddi,

Luchino Chessa

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(2), P. 273 - 273

Published: Jan. 27, 2023

Vaccine hesitancy and conspiracy beliefs among healthcare workers (HCWs) represent operational priorities that require urgent attention. Identifying classifying specific subpopulation of is crucial to customize educational intervention strategies enhance the acceptance uptake rate vaccination. Thus, main purpose our study was empirically identify latent profiles vaccine Italian HCWs adopting a person-centered approach investigating their relationships with antecedents intention get fourth dose COVID-19 vaccine. We conducted profile analyses (LPA) different configurations based on five vaccination: confidence, complacency, constraints, calculation, collective responsibility sample (n = 573). LPA revealed four distinct profiles: believer (61.5%), middler (24.7%), hesitant (9.00%), rejecter (4.7%). Having associated greater likelihood membership in all but believer. Finally, lowest rejector profiles. Theoretical contributions implications for practice are discussed.

Language: Английский

Citations

10